The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency

Quality of Life Research

Volumn 8, Issue 4, 1999, Pages 373-383

  McKenna, Stephen P ^a   Doward, Lynda C ^a   Alonso, Jordi ^b   Kohlmann, Thomas ^e   Niero, Mauro ^c   Prieto, Luis ^b   Wiren, Lena ^d  

^a GALEN RESEARCH   (United Kingdom)

^b Inst Munic d'Incestigacio Medica   (Spain)

^c CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e Galen Research ^*

Author keywords

Cross cultural; Growth hormone deficiency; Needs; Quality of life

Indexed keywords

ADULT; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HEALTH CARE NEED; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; MALE; MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; RISK ASSESSMENT; WELLBEING;

ADULT; CROSS-CULTURAL COMPARISON; EUROPE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TRANSLATING;

EID: 0032776092     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008987922774     Document Type: Article

References (24)

1. 1. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituilarism following external radiation therapy for pituitary tumours in adults. Quarterly Journal of Medicine 1989; 70: 145-160.
2. 2. Bengtsson B-Ä. The consequences of growth hormone deficiency in adults. Acta Endocrinologica 1993; 128(Suppl 2): 2-5.
3. 3. Rudman D, Kutner M, Rogers C. Impaired growth hormone secretion in the adult population. Relation to age and adiposity. Journal of Clinical Investigation 1981; 67: 1361-1369.
4. 4. Salomon S, Cunco R, Hesp R, Sönksen P. Growth hormone deficiency in adults. Acta Paediatrica. Scandinavica 1989; 356(suppl): 69.
5. 5. Blizzard R, Joyce S, Mitchell T, Johanson A, Libber S, Plotnick L, Migeon C. Psychosocial impact of long-term growth hormone therapy. In: Raita S, Tolman R, eds, Human Growth Hormone. New York: Plenum 1986: p. 93.
6. 6. Hunt SM, McEwen J, McKenna SP. Measuring Health Status. London: Croom Helm 1986.
7. 7. Dupuy H. The Psychological General Well-Being Index. In: Wenger N, ed. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Jacq. 1984: p. 170.
8. 8. McKenna SP, Hunt SM. The General Well-Being Index: adapting and retesting an American measure for use in the United Kingdom. British Journal of Medical Economics 1992; 4: 41-50.
9. 9. Björk S, Jonsson B, Westphal O, Levin J-E. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatrica. Scandinavica 1989; 356 (suppl): 55-59.
10. 10. Rosén T, Wirén L, Wilhemsen L, Wiklund I, Bengtsson B-Ā. Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 1994; 40: 111-116.
11. 11. McGauley G. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica 1989; 356(Suppl): 70-72.
12. 12. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology 1992; 36: 45-52.
13. 13. Bengtsson B-Å. Edén S, Lönn L. Treatment of adults with growth hormone deficiency with recombinant human growth hormone. Journal of Clinical Endocrinology and Metabolism 1993; 76: 309-17.
14. 14. Mârdh G, Lundin K, Borg G, Jonsson B, Lindeberg A. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled clinical trials. Endocrinology and Metabolism 1994; 1(Suppl): 43-49.
15. 15. NHS. National Health Service Review. Working Paper No 6 Medical Audit. London: HMSO, 1989.
16. 16. CCOHTA (Canadian Coordinating Office for Health Technology Assessment). Guidelines for economic evaluation of pharmaceuticals: Canada. 2nd edn. Ottowa: CCOHTA, 1997.
17. 17. More T. Utopia. London: Chatto & Windus, 1908.
18. 18. Hunt SM, McKenna SP. The QLDS: A scale for the measurement of quality of life in depression. Health Policy 1992; 22: 307-319.
19. 19. Hörnquist JO. The concept of quality of life. Scandinavian Journal of Social Medicine 1982; 10: 57-61.
20. 20. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: A rheumatoid arthritis-specific quality of life instrument. British Journal of Rheumatology (in press).
21. 21. Weiner E, Stewart B. Assessing Individuals. Boston: Little Brown, 1984.
22. 22. McDowell I. Newell C. Measuring Health: a Guide to Rating Scales and Questionnaires. Oxford: Oxford University Press, 1987.
23. 23. McKenna SP, Koppeschaar HPF, Zelissen PMJ, Snel YEM, Whalley D, Doward LC. The impact of replacement GII on the quality of life of patients: Results of a clinical trial in the Netherlands. Endocrinology and Metabolism 1997; 4 (Suppl B): 167.
24. 24. McKenna SP, Vazquez JA, Pico A, Escobar F, Torres E, Ulied A, Whalley D, Doward LC. The quality of life of adult GHD patients in Spain and the effects of replacement therapy with Genotropin. Endocrinology and Metabolism 1997; 4 (Suppl B): 168.